Anti-Tac (daclizumab, Zenapax) in the Treatment of Leukemia, Autoimmune Diseases, and in the Prevention of Allograft Rejection: A 25-Year Personal Odyssey

✍ Scribed by Thomas A. Waldmann

• Book ID: 106405680
• Publisher: Springer
• Year: 2007
• Tongue: English
• Weight: 409 KB
• Volume: 27
• Category: Article
• ISSN: 0271-9142
• DOI: 10.1007/s10875-006-9060-0